2023
|
Invention
|
Use of pyrrolopyrimidine compound in treatment of acute graft versus host disease. Provided is th... |
2022
|
Invention
|
Use of macrocyclic compound containing amino in treatment of trk kinase-mediated tumors. The use ... |
|
Invention
|
Use of aminopyrazolopyrimidine compound in treatment of trk kinase-mediated tumor. The present in... |
|
Invention
|
Crystal of amino pyrazolopyrimidine compound. Provided are a crystal of an amino pyrazolopyrimidi... |
|
Invention
|
Use of pyrrolopyrimidine compound and pharmaceutical composition thereof for treating chronic gra... |
2021
|
Invention
|
Crystalline forms of 4-(tert-butoxyamino)-6-(6-(trifluoromethyl)pyridin-2-yl)-n-(2-(trifluorometh... |
|
Invention
|
Use of pyrrolopyrimidine compound for treating hemophagocytic syndrome.
The present invention re... |
|
Invention
|
Use of pyrrolopyrimidine compound for treating hemophagocytic syndrome. The present invention rel... |
2020
|
Invention
|
Combined pharmaceutical composition of quinazoline derivative or salt thereof and use thereof. Th... |
|
Invention
|
Pharmaceutical composition comprising quinazoline derivative or salt thereof.
A solid pharmaceut... |
|
Invention
|
Pharmaceutical composition comprising quinazoline derivative or salt thereof. A solid pharmaceuti... |
|
Invention
|
Use of quinazoline derivative or salt thereof or pharmaceutical composition thereof. Disclosed is... |
|
Invention
|
Method for preparing quinazoline derivative and crystallization thereof. The present application ... |
|
Invention
|
Crystals of aniline pyrimidine compound serving as egfr inhibitor.
The present application belon... |
2019
|
Invention
|
Treatment use of pyrrolopyrimidine compound, and solid pharmaceutical composition of pyrrolopyrim... |
|
Invention
|
Salts of substituted pyrrolopyrimidine cdk inhibitor, crystal and use thereof. The present applic... |
|
Invention
|
Solid pharmaceutical composition containing 1,3,5-triazine derivative or salt thereof. A solid ph... |
|
Invention
|
Iminosulfanone compound as bromodomain protein inhibitor and pharmaceutical composition and medic... |
|
Invention
|
Sulfoximine compound as bromodomain protein inhibitor and pharmaceutical composition and medical ... |
2018
|
Invention
|
Crystalline sulfamide compound. The present application relates to a crystalline sulfamide compou... |
|
Invention
|
Macrocycle containing aminopyrazole and pyrimidine and pharmaceutical composition and use thereof... |
|
Invention
|
Urea compound as dual inhibitor of ido and tdo. Provided are a urea compound having a dual inhibi... |
|
Invention
|
1,3,5-triazine derivative salt, crystal, preparation method, pharmaceutical composition and use t... |
2017
|
Invention
|
Amino pyrazolopyrimidine compound used as neurotrophic factor tyrosine kinase receptor inhibitor.... |
|
Invention
|
Crystal of salt of quinazoline derivative. Disclosed are a crystal of a maleate of a compound of ... |
|
Invention
|
Crystal of dpp-iv long-acting inhibitor and salt. The present application relates to a crystal of... |
|
Invention
|
Pyrrolopyrimidine crystal for preparing jak inhibitor. The present application relates to the fie... |
|
Invention
|
Preparation method for chiral pyrrolopyrimidine compound. Provided are a preparation method for a... |
|
Invention
|
Pyrrolopyrimidine comprising cyclopentyl substituent. A pyrrolopyrimidine comprising a cyclopenty... |
|
Invention
|
Substituted pyrrolopyrimidine cdk inhibitor, pharmaceutical composition containing same and use t... |
|
Invention
|
Iridinesulfonamide compound and use method thereof. An iridinesulfonamide compound having isocitr... |
|
Invention
|
Sultam compound and application method thereof. Provided are a sultam compound having isocitrate ... |
|
Invention
|
Tricyclic compound for bromodomain-containing protein inhibitor and preparation pharmaceutical co... |
2016
|
Invention
|
1,3,5-triazine derivative and method of using same. Disclosed are compounds having formulae I and... |
|
Invention
|
Pyridine substituted 2-aminopyridine protein kinase inhibitor crystal. The present invention disc... |
|
Invention
|
Antitumor compound targeting idh2 mutation and method of use thereof. The present application rel... |
|
Invention
|
N-(2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-((4-(3-methyl-2-oxo-2,3-dihydro-1h-benzo... |
2015
|
Invention
|
Pyrrolopyrimidine compound. The present application relates to the field of pharmaceutical chemis... |